Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Deep learning models can enable accurate and efficient disease diagnosis, but have thus far been hampered by the data scarcity present in the medical world. Automated diagnosis studies have been constrained by underpowered single-center datasets, and although some results have shown promise, their generalizability to other institutions remains questionable as the data heterogeneity between institutions is not taken into account. By allowing models to be trained in a distributed manner that preserves patients' privacy, federated learning promises to alleviate these issues, by enabling diligent multi-center studies. We present the first simulated federated learning study on the modality of cardiovascular magnetic resonance and use four centers derived from subsets of the M&M and ACDC datasets, focusing on the diagnosis of hypertrophic cardiomyopathy. We adapt a 3D-CNN network pretrained on action recognition and explore two different ways of incorporating shape prior information to the model, and four different data augmentation set-ups, systematically analyzing their impact on the different collaborative learning choices. We show that despite the small size of data (180 subjects derived from four centers), the privacy preserving federated learning achieves promising results that are competitive with traditional centralized learning. We further find that federatively trained models exhibit increased robustness and are more sensitive to domain shift effects.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894335PMC
http://dx.doi.org/10.1038/s41598-022-07186-4DOI Listing

Publication Analysis

Top Keywords

federated learning
16
learning
6
federated
4
learning multi-center
4
multi-center imaging
4
imaging diagnostics
4
diagnostics simulation
4
simulation study
4
study cardiovascular
4
cardiovascular disease
4

Similar Publications

Learning from history for personalized federated learning.

Neural Netw

September 2025

College of Information Science, North China University of Technology, Beijing, China. Electronic address:

Personalized Federated Learning (pFL) has received extensive attentions, due to its ability to effectively process non-IID data distributed among different clients. However, most of the existing pFL methods focus on the collaboration between global and local models to enrich the personalization process, but ignoring a lot of valuable historical information, which represents the unique learning trajectory of each client. In this paper, we propose a pFL method called FedLFH, which introduces a tracking variable that allows each client to preserve historical information to facilitate personalization.

View Article and Find Full Text PDF

Applications of Federated Large Language Model for Adverse Drug Reactions Prediction: Scoping Review.

J Med Internet Res

September 2025

Department of Information Systems and Cybersecurity, The University of Texas at San Antonio, 1 UTSA Circle, San Antonio, TX, 78249, United States, 1 (210) 458-6300.

Background: Adverse drug reactions (ADR) present significant challenges in health care, where early prevention is vital for effective treatment and patient safety. Traditional supervised learning methods struggle to address heterogeneous health care data due to their unstructured nature, regulatory constraints, and restricted access to sensitive personal identifiable information.

Objective: This review aims to explore the potential of federated learning (FL) combined with natural language processing and large language models (LLMs) to enhance ADR prediction.

View Article and Find Full Text PDF

Protein kinases are central regulators of cell signaling and play pivotal roles in a wide array of diseases, most notably cancer and autoimmune disorders. The clinical success of kinase inhibitors-such as imatinib and osimertinib-has firmly established kinases as valuable drug targets. However, the development of selective, potent inhibitors remains challenging due to the conserved nature of the ATP-binding site, off-target effects, resistance mutations, and patient-specific variability.

View Article and Find Full Text PDF

Large-scale genomics data combined with Electronic Health Records (EHRs) illuminate the path towards personalized disease management and enhanced medical interventions. However, the absence of "gold standard" disease labels makes the development of machine learning models a challenging task. Additionally, imbalances in demographic representation within datasets compromise the development of unbiased healthcare solutions.

View Article and Find Full Text PDF

Early diagnosis of Parkinson's disease (PD) is crucial for timely treatment and disease management. Recent studies link PD to impaired facial muscle control, manifesting as "masked face" symptoms, offering a novel diagnostic approach through facial expression analysis. However, data privacy concerns and legal restrictions have resulted in significant "data silos", hindering data sharing and limiting the accuracy and generalizability of existing diagnostic models due to small, localized datasets.

View Article and Find Full Text PDF